NORMA Group SE
- WKN: A1H8BV
- ISIN: DE000A1H8BV3
- Land: Deutschland
Nachricht vom 17.05.2018 | 15:28
Lars Magnus Berg new Chairman of the Supervisory Board of NORMA Group SE
DGAP-News: NORMA Group SE / Key word(s): AGM/EGM/Change of Personnel
Maintal, May 17, 2018 - At today's Annual General Meeting of NORMA Group SE in Frankfurt/Main, Dr. Stefan Wolf was voted down as Chairman of the Supervisory Board with 50.41% of the votes against him. The Supervisory Board elected Lars Magnus Berg as his successor. Mr. Berg has been Deputy Chairman of the Supervisory Board of NORMA Group SE for many years. Erika Schulte was elected as his Deputy. In addition to the previous members of Lars Magnus Berg, Günter Hauptmann, Dr. Knut J. Michelberger and Erika Schulte, who were re-elected to the Supervisory Board by the Annual General Meeting for a further five years, the Annual General Meeting elected new member Rita Forst. The election of Rita Forst and Erika Schulte achieves the target share of women of at least one third of the members on the Supervisory Board.
Rita Forst studied mechanical engineering and is an expert in the field of drive and vehicle technology. She also has many years of experience both as a member of the Management Board and in various management positions in globally operating automotive companies. Her international experience and above all her technical expertise in research and development at a leading global automotive company are of particular benefit to her membership on the Supervisory Board of NORMA Group SE.
"We are delighted that NORMA Group has been able to add Rita Forst to the Supervisory Board. Mrs. Forst brings valuable expertise in the technological areas vital for NORMA Group," said Lars Magnus Berg, Chairman of the Supervisory Board of NORMA Group SE. "We are proud to welcome such a top-class expert of international standing to the Supervisory Board of NORMA Group SE and look forward to the future exchange."
Mrs. Forst succeeds Dr. Christoph Schug, who left the Supervisory Board of NORMA Group SE with effect from the close of the Annual General Meeting on May 17, 2018. "All members of the Supervisory Board of NORMA Group SE would like to express their thanks to Dr. Schug and Dr. Wolf for their many years of commitment and trusting cooperation. We have always maintained a good and constructive exchange with both members on a professional and personal level. The entire Group wishes Dr. Schug and Dr. Wolf all the best and every success in their further projects," said Lars Magnus Berg.
NORMA Group SE increases dividend for the sixth time in a row
The voting results and further information on the Annual General Meeting can be found on the Investor Relations website: http://investors.normagroup.com/en/agm. Additional information on the company on www.normagroup.com. Press photos are available from our platform at www.normagroup.com/images.
|Company:||NORMA Group SE|
|Phone:||+49 6181 6102 741|
|Fax:||+49 6181 6102 7641|
|Listed:||Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange|
|End of News||DGAP News Service|
Lars Magnus Berg new Chairman of the Superviso ...
NORMA Group SE: Supervisory Board Chairman Dr. ...
NORMA Group with strong organic growth in the ...
NORMA Group SE increases its sales forecast fo ...
NORMA Group SE: NORMA Group SE increases its s ...
GBC im Fokus
M1 Kliniken: Geschäftsjahr über den Erwartungen
Mit dem deutlichen Anstieg auf 21 Klinikstandorte (Ende 2016: 13) hat die auf ästhetische Medizin spezialisierte M1 Kliniken AG die Basis für einen Ausbau der Umsatz- und Ertragsbasis gelegt. Hinzu kommt die bereits in Umsetzung befindliche Erschließung weiterer Umsatzströme, wie etwa die Erweiterung der Eigenmarken oder die Abdeckung der ästhetischen Zahnmedizin. Das Kursziel beläuft sich auf 18,50 € und das Rating lautet KAUFEN.
Der AKTIONÄR News
20. Mai 10:00 Geliebter Beton: Die Weitsichtigen
20. Mai 09:33 Elite Defensiv Index: Eine sichere Bank
20. Mai 08:30 EOS – Der Ethereum-Killer?
19. Mai 10:17 Morphosys – geballte Pipeline-Power
18. Mai 2018
Original-Research: Energiekontor AG (von First Berlin Equity Research GmbH): Buy
18. Mai 2018